News

When Life Doesn’t Pause: A Young Adult’s Story of Family, Work, and Brain Cancer Melissa M. sat in the OR waiting room, one hand resting on her belly, the other gripping a hospital chair. At nine months pregnant, she was about to give birth to their daughter — but first, her husband, Joe, had to make it through a craniotomy following a brain tumor recurrence. “It was so hard,” […] April 1, 2025

New Brain Tumor Clinical Trials: April – October 2024 It can be hard to keep track of new clinical trial opportunities opening across the United States. There are many clinical trials actively enrolling patients. This report provides a summary of the studies that have recently opened or started recruiting since our last report for patients with a primary brain tumor. Follow the hyperlink for […] November 7, 2024

Updated: Exciting News for Patients with Grade 2 Oligodendroglioma and Astrocytoma UPDATED (August 6, 2024): The U.S. Food and Drug Administration (FDA) has approved vorasidenib (brand name: Voranigo) for the treatment of adult and pediatric patients 12 years of age and older with grade 2 astrocytoma or oligodendroglioma with an IDH1 or IDH2 mutation, following surgery including biopsy, sub-total resection, or gross total resection. This is […] August 6, 2024

New Brain Tumor Clinical Trials: January – March 2024 It can be hard to keep track of new clinical trial opportunities opening across the United States. There are many clinical trials actively enrolling patients. This report provides a summary of the studies that have recently opened or started recruiting (January 1, 2024 – April 9, 2024) for patients with a primary brain tumor*. Follow […] April 12, 2024

Brain Tumor Diagnosis Spurs Nomadic Lifestyle A brain tumor diagnosis in 2014 quickly grounded Dace H.’s fast-paced job at a technology start-up. The life change pushed Dace to slow down and focus on the things that mean the most to him — spending time with friends and family, being in nature, and exploring his creativity through writing and photography. From there, he […] May 16, 2023